Our results also highlight the importance of the Wnt/β-catenin inhibitors (GSK3β and Dvl) and their transcriptional targets (including c-Myc, survivin, cyclin D1, CDK4, and MMPs), which may serve as future targets for the development of therapeutic strategies against human melanoma. This evidence concerns the gene CCND1 and melanoma.